NCT07026760

Brief Summary

This study investigates the immediate effects of different parameters (frequency and intensity) of trans-spinal magnetic stimulation (TsMS) on cortical excitability in healthy individuals. Using a randomized, double-blind crossover design, the research aims to identify optimal stimulation protocols for modulating neural activity. Outcomes include measurements of motor-evoked potentials (MEP), intracortical inhibition (ICI), and facilitation (ICF). Findings may enhance non-invasive therapeutic strategies for neurological disorders.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Oct 2022

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

June 10, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

3 years

First QC Date

June 10, 2025

Last Update Submit

June 10, 2025

Conditions

Keywords

Trans-spinal magnetic stimulationCortical Excitability

Outcome Measures

Primary Outcomes (1)

  • Cortical excitability

    Cortical excitability will be assessed using motor-evoked potentials (MEPs) elicited by single-pulse transcranial magnetic stimulation (TMS) over the primary motor cortex (M1), specifically targeting the cortical representation of the first dorsal interosseous (FDI) muscle. The stimulation hotspot will be defined as the scalp location that elicits the largest and most consistent MEP amplitude at the lowest stimulation intensity. Single-pulse TMS will be delivered at 100% of the resting motor threshold (RMT). Paired-pulse TMS protocols will be used to evaluate intracortical inhibition (ICI) and intracortical facilitation (ICF), using a subthreshold conditioning stimulus set at 80% of RMT and a suprathreshold test stimulus set at 120% of RMT, with interstimulus intervals of 3 ms for ICI and 10 ms for ICF. MEP amplitudes will be recorded from the FDI muscle using bipolar surface electromyography (EMG). Signals will be digitized at 20,000 Hz (bandpass 5-10,000 Hz) for offlin

    Baseline (T0), immediately post-stimulation (T1), and at 15 (T2) and 30 minutes (T3) after stimulation.

Study Arms (9)

Trans-spinal magnetic stimulation (1 Hz + 90% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (90% MT + 1 Hz)

Trans-spinal magnetic stimulation (1 Hz + 100% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (100% MT + 1 Hz)

Trans-spinal magnetic stimulation (1 Hz + 110% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (110% MT + 1 Hz)

Trans-spinal magnetic stimulation (10 Hz + 90% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (90% + 10 Hz)

Trans-spinal magnetic stimulation (10 Hz + 100% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (100% MT + 10 Hz)

Trans-spinal magnetic stimulation (10 Hz + 110% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (110% MT + 10 Hz)

Trans-spinal magnetic stimulation (25 Hz + 90% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (90% MT + 25 Hz)

Trans-spinal magnetic stimulation (25 Hz + 100% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (100% MT + 25 Hz)

Trans-spinal magnetic stimulation (25 Hz + 110% MT)

ACTIVE COMPARATOR
Device: Trans-spinal magnetic stimulation (110% MT + 25 Hz)

Interventions

Low frequency stimulation (1 Hz) at 90% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (1 Hz + 90% MT)

Low frequency stimulation (1 Hz) at 100% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (1 Hz + 100% MT)

Low frequency stimulation (1 Hz) at 110% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (1 Hz + 110% MT)

High frequency stimulation (10 Hz) at 90% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (10 Hz + 90% MT)

High frequency stimulation (10 Hz) at 100% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (10 Hz + 100% MT)

High frequency stimulation (10 Hz) at 110% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (10 Hz + 110% MT)

High frequency stimulation (25 Hz) at 90% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (25 Hz + 90% MT)

High frequency stimulation (25 Hz) at 100% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (25 Hz + 100% MT)

High frequency stimulation (25 Hz) at 110% of resting motor threshold intensity, delivering a total of 2400 pulses.

Trans-spinal magnetic stimulation (25 Hz + 110% MT)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • Pregnancy; history of seizures or epilepsy; metallic implants in the head, spine, face, or heart; diagnosed neurological or musculoskeletal conditions that could interfere with assessments or interventions; or use of substances that alter nervous system excitability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal de Pernambuco

Recife, Pernambuco, 50740-560, Brazil

RECRUITING

Central Study Contacts

Kátia Monte-Silva

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 10, 2025

First Posted

June 18, 2025

Study Start

October 1, 2022

Primary Completion

September 30, 2025

Study Completion

October 30, 2025

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations